BMC is headquartered in the Zhongguancun Science Park in Beijing, China, and has received such significant honors as National High-Tech Enterprise and Zhongguancun High-Tech Enterprise. As the domestic industry leader, BMC provides innovative solutions for global families on the diagnosis, treatment, and management of sleep-disordered breathing (SDB) and other chronic respiratory diseases. BMC¡¯s product portfolio includes SDB diagnostic devices, flow generators, and patient interfaces. The co***ny has received the internationally recognized ISO 13485 quality management system certification, and obtained CFDA clearance from China, CE marking from the European Union, FDA clearance from the United States, and regulatory approval from many other countries. It has successfully established a worldwide distribution and service network covering more than 80 countries and regions.
BMC devotes millions of dollars to multiple R&D centers in China every year, and has accumulated a considerable number of patents, trademarks, and software patents worldwide. The co***ny opened a new manufacturing center in Tianjin in 2014, which greatly increased its manufacturing capacity, and has set up customer experience centers across major Chinese cities, taking the lead in providing more users with an intuitive and convenient product experience.
BMC released the second-generation flow generator RESmart GII with two innovative features of oxygen saturation monitoring and iCode data collection in 2014, and officially launched BMCares£¨BMC+£©, the first professional telehealth platform in China specifically designed for flow generator users, in the next year.
Holding the core value of ¡°family cares¡±, BMC is firmly committed to partnering with families worldwide to overcome the discomfort of chronic respiratory disease with quality products, professional services, and proactive care, keenly seeking to become the first choice in respiratory care.
|
Home
